Two Sigma Securities, LLC Medicenna Therapeutics Corp. Transaction History

Two Sigma Securities, LLC

  • $5.78 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$0.28 - $0.51 $6,077 - $11,070
21,706 Added 132.47%
38,092 $11,000
Q2 2023

Aug 14, 2023
BUY
$0.44 - $0.82 $833 - $1,553
1,895 Added 13.08%
16,386 $7,000
Q1 2023

May 15, 2023
SELL
$0.5 - $0.78 $10,697 - $16,687
-21,394 Reduced 59.62%
14,491 $9,000
Q4 2022

Feb 14, 2023
BUY
$0.4 - $0.68 $14,354 - $24,401
35,885 New
35,885 $16,000

Others Institutions Holding MDNA

# of Institutions
3
Shares Held
863K
Call Options Held
0
Put Options Held
0
View Full List

About Medicenna Therapeutics Corp.

MDNA Quotes by TradingView
  • Ticker MDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,637,504
  • Market Cap $21.6M
  • Description
  • Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as...
More about MDNA
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email